Compare EXTR & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXTR | MMSI |
|---|---|---|
| Founded | 1996 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.1B |
| IPO Year | 1999 | 1996 |
| Metric | EXTR | MMSI |
|---|---|---|
| Price | $29.55 | $70.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $21.20 | ★ $98.88 |
| AVG Volume (30 Days) | ★ 2.3M | 827.2K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.91 | 4.93 |
| EPS | 0.18 | ★ 0.68 |
| Revenue | $1,140,067,000.00 | ★ $1,515,906,000.00 |
| Revenue This Year | $13.33 | $8.85 |
| Revenue Next Year | $7.97 | $5.88 |
| P/E Ratio | $165.56 | ★ $104.54 |
| Revenue Growth | 2.05 | ★ 11.75 |
| 52 Week Low | $13.48 | $59.74 |
| 52 Week High | $33.10 | $96.74 |
| Indicator | EXTR | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 51.88 | 62.78 |
| Support Level | $27.59 | $66.19 |
| Resistance Level | N/A | $71.68 |
| Average True Range (ATR) | 1.31 | 2.12 |
| MACD | -0.37 | 0.32 |
| Stochastic Oscillator | 10.81 | 79.45 |
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.